MedicarePartD.guide

A non-government resource built from CMS public data

COVID-19 and flu antivirals on BlueMedicare Value Rx (S5795-003)

Paxlovid, Lagevrio, oseltamivir and Xofluza, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Arkansas
Premium
$52.50/month
Deductible
$615.00
Change plan

2 of 4 COVID and flu antivirals are covered on this plan. None require prior authorization.

2 aren't on the formulary (Lagevrio and Xofluza).

  • Paxlovid
    nirmatrelvir and ritonavir
    Covered
    $5.00
    Tier 2
  • oseltamivir
    generic Tamiflu
    Covered
    from $1.36
    Tier 3
Not on the formulary
Lagevrio, Xofluza

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list